Christina Rautenberg

Author

Heinrich Heine University Düsseldorf ORCID

Also Known As

C. Rautenberg, Christina Rautenberg

Publications

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Düsseldorf University Hospital Universität Hamburg University Medical Center Hamburg-Eppendorf Heidelberg University

About

Christina Rautenberg is an author at Heinrich Heine University Düsseldorf specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	284
2	Health Sciences	3	3	118
3	Blood Transplantation	2	2	101
4	Public Health	1	1	10
5	Cell Biology	1	1	14

Christina Rautenberg

Publications

737

Citations

H-Index

Page 1

	Year	Citations
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Thomas Schroeder, Christina Rautenberg, William Krüger, Annals of Hematology Cell TherapyTransplantationMarrow TransplantationMulticenter AnalysisStem Cell Transplantation	2017	75
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia Thomas Schroeder, Nadija Wegener, Michael Lauseker, Biology of Blood and Marrow Transplantation Mixed-phenotype Acute LeukemiaImmunologyCtx GroupImmunotherapyCtx-refractory Disease	2019	75
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, Annals of Hematology	2020	65
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Blood Cancer Journal	2021	62
Sorafenib and azacitidine as salvage therapy for relapse of <scp>FLT</scp>3‐<scp>ITD</scp> mutated <scp>AML</scp> after allo‐<scp>SCT</scp> Christina Rautenberg, Kathrin Nachtkamp, Ariane Dienst, European Journal Of Haematology	2016	47
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation Christina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, Biology of Blood and Marrow Transplantation	2018	47
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation Christina Rautenberg, Anika Bergmann, Ulrich Germing, Cancers	2020	47
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation Nico Gagelmann, Anita Badbaran, Dietrich W. Beelen, Blood Advances	2021	37
Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation Christina Rautenberg, Jennifer Kaivers, Ulrich Germing, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationCell AplasiaStem Cell Transplantation	2019	31
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies Esther Schuler, Sarah Boughoufala, Christina Rautenberg, Annals of Hematology Hematological MalignancyTreatment StrategiesTransplantationMarrow TransplantationRelapse Patterns	2019	29

Page 1